Detalhe da pesquisa
1.
Binding and detoxification efficiency of albumin decline after haemodialysis.
Nephrol Dial Transplant
; 39(2): 215-221, 2024 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37558390
2.
Albumin redox state of maintenance haemodialysis patients is positively altered after treatment.
BMC Nephrol
; 24(1): 273, 2023 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37723426
3.
Relapsing and Progressive Complications of Severe Hypertriglyceridemia: Effective Long-Term Treatment with Double Filtration Plasmapheresis.
Blood Purif
; 49(4): 457-467, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32191938
4.
Real-world study: Escalating targeted lipid-lowering treatment with PCSK9-inhibitors and lipoprotein apheresis.
J Clin Apher
; 34(4): 423-433, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30817043
5.
Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia-target attainment requires further increase of intensity.
Pediatr Nephrol
; 33(7): 1199-1208, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29502162
6.
Predictive role of fluctuating biochemical parameters for mortality in hemodialysis patients.
Ther Apher Dial
; 26(6): 1137-1147, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35038241
7.
Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis.
Am J Cardiol
; 136: 38-48, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32946862
8.
Efficacy of lipid reduction with DALI and MONET.
Atheroscler Suppl
; 30: 217-224, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29096841
9.
Safety aspects of lipidapheresis using DALI and MONET - Multicenter observational study.
Atheroscler Suppl
; 30: 225-231, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29096842